Sunday - May 03, 2026

Category Archives: Professional Services

Inflammatory Bowel Disease Market: Growth Momentum Across 7MM to 2034 – DelveInsight | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly and Company, Gilead, Galapagos, Applied Moleculara

The Key Inflammatory Bowel Disease Companies in the market include – AbbVie, Janssen Pharmaceuticals, Abivax, Morphic Therapeutic, CJ Bioscience/4D Pharma, RedHill Biopharma, Tryp Therapeutics, Eli Lilly and Company, Gilead, Galapagos, Applied Molecular Transport, Protagonist Therapeutics, Janssen, AstraZeneca, Vifor Pharma, Astellas … Continue reading →

Parkinson’s Disease Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Parkinson’s Disease pipeline constitutes 80+ key companies continuously working towards developing 100+ Parkinson’s Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Axial Spondyloarthritis Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Janssen Pharma, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharma, Galapago, Kyowa Kirin Co, Eli Lilly

The Key Axial Spondyloarthritis Companies in the market include – Janssen Pharmaceuticals, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme LLC, Pfizer, Novartis, Jiangsu HengRui Medicine, UCB Biopharma, … Continue reading →

Osteoarthritis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observe | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corp

The Key Osteoarthritis Companies in the market include – Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, and others.   DelveInsight’s report, “Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2034,” … Continue reading →

TELECO Launches AI-Powered Cybersecurity Platform Delivering 24/7 Threat Protection

AI Cybersecurity Suite TELECO launches an AI-powered cybersecurity platform delivering 24/7 threat protection, real-time monitoring, zero-trust architecture, and compliance support. Designed for businesses of all sizes, the platform helps organizations stay secure against evolving cyber threats without the cost of … Continue reading →

Schizophrenia Market: Investment-Ready Growth Trends to 2034 – DelveInsight | Teva Pharma, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharma, Reviva Pharma, Minerva Neurosciences

The Key Schizophrenia Companies in the market include – Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, Minerva Neurosciences, AstraZeneca, Eli Lilly … Continue reading →